▶ 調査レポート

ドラベ症候群治療の世界市場（～2026年）
• 英文タイトル：Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ドラベ症候群治療の世界市場（～2026年） / Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY11711資料のイメージです。• レポートコード：MRC2-11QY11711
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ドラベ症候群治療の競争状況、市場シェア
・世界のドラベ症候群治療市場：種類別市場規模 2015年-2020年（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））
・世界のドラベ症候群治療市場：種類別市場規模予測 2021年-2026年（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））
・世界のドラベ症候群治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、Eコマース、その他）
・世界のドラベ症候群治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、Eコマース、その他）
・北米のドラベ症候群治療市場分析：米国、カナダ
・ヨーロッパのドラベ症候群治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのドラベ症候群治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のドラベ症候群治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのドラベ症候群治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Biocodex、Epygenix Therapeutics、GW Pharmaceuticals、OPKO Health、Zogenix
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells.
Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include clobazam (Onfi, Frisium) and valproic acid (Depakote, Depakene). Second line treatments include stiripentol (Diacomit), topiramate (Topamax), and the ketogenic diet.

Market Analysis and Insights: Global Dravet Syndrome Treatment Market
The global Dravet Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Dravet Syndrome Treatment Scope and Market Size
Dravet Syndrome Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dravet Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Biocodex
Epygenix Therapeutics
GW Pharmaceuticals
OPKO Health
Zogenix
…

Market segment by Type, the product can be split into
First-generation Drug (FGD)
Second-generation Drug (SGD)
Third-generation Drug (TGD)
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
E- Commerce
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dravet Syndrome Treatment Revenue
1.4 Market by Type
1.4.1 Global Dravet Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 First-generation Drug (FGD)
1.4.3 Second-generation Drug (SGD)
1.4.4 Third-generation Drug (TGD)
1.5 Market by Application
1.5.1 Global Dravet Syndrome Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 E- Commerce
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Dravet Syndrome Treatment Market Perspective (2015-2026)
2.2 Global Dravet Syndrome Treatment Growth Trends by Regions
2.2.1 Dravet Syndrome Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dravet Syndrome Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Dravet Syndrome Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dravet Syndrome Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Dravet Syndrome Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Dravet Syndrome Treatment Players by Market Size
3.1.1 Global Top Dravet Syndrome Treatment Players by Revenue (2015-2020)
3.1.2 Global Dravet Syndrome Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Dravet Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dravet Syndrome Treatment Market Concentration Ratio
3.2.1 Global Dravet Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Treatment Revenue in 2019
3.3 Dravet Syndrome Treatment Key Players Head office and Area Served
3.4 Key Players Dravet Syndrome Treatment Product Solution and Service
3.5 Date of Enter into Dravet Syndrome Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Dravet Syndrome Treatment Historic Market Size by Type (2015-2020)
4.2 Global Dravet Syndrome Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Dravet Syndrome Treatment Market Size by Application (2015-2020)
5.2 Global Dravet Syndrome Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Dravet Syndrome Treatment Market Size (2015-2020)
6.2 Dravet Syndrome Treatment Key Players in North America (2019-2020)
6.3 North America Dravet Syndrome Treatment Market Size by Type (2015-2020)
6.4 North America Dravet Syndrome Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Dravet Syndrome Treatment Market Size (2015-2020)
7.2 Dravet Syndrome Treatment Key Players in Europe (2019-2020)
7.3 Europe Dravet Syndrome Treatment Market Size by Type (2015-2020)
7.4 Europe Dravet Syndrome Treatment Market Size by Application (2015-2020)

8 China
8.1 China Dravet Syndrome Treatment Market Size (2015-2020)
8.2 Dravet Syndrome Treatment Key Players in China (2019-2020)
8.3 China Dravet Syndrome Treatment Market Size by Type (2015-2020)
8.4 China Dravet Syndrome Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Dravet Syndrome Treatment Market Size (2015-2020)
9.2 Dravet Syndrome Treatment Key Players in Japan (2019-2020)
9.3 Japan Dravet Syndrome Treatment Market Size by Type (2015-2020)
9.4 Japan Dravet Syndrome Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Dravet Syndrome Treatment Market Size (2015-2020)
10.2 Dravet Syndrome Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dravet Syndrome Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Dravet Syndrome Treatment Market Size by Application (2015-2020)

11 India
11.1 India Dravet Syndrome Treatment Market Size (2015-2020)
11.2 Dravet Syndrome Treatment Key Players in India (2019-2020)
11.3 India Dravet Syndrome Treatment Market Size by Type (2015-2020)
11.4 India Dravet Syndrome Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Dravet Syndrome Treatment Market Size (2015-2020)
12.2 Dravet Syndrome Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Dravet Syndrome Treatment Market Size by Type (2015-2020)
12.4 Central & South America Dravet Syndrome Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Biocodex
13.1.1 Biocodex Company Details
13.1.2 Biocodex Business Overview
13.1.3 Biocodex Dravet Syndrome Treatment Introduction
13.1.4 Biocodex Revenue in Dravet Syndrome Treatment Business (2015-2020))
13.1.5 Biocodex Recent Development
13.2 Epygenix Therapeutics
13.2.1 Epygenix Therapeutics Company Details
13.2.2 Epygenix Therapeutics Business Overview
13.2.3 Epygenix Therapeutics Dravet Syndrome Treatment Introduction
13.2.4 Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.2.5 Epygenix Therapeutics Recent Development
13.3 GW Pharmaceuticals
13.3.1 GW Pharmaceuticals Company Details
13.3.2 GW Pharmaceuticals Business Overview
13.3.3 GW Pharmaceuticals Dravet Syndrome Treatment Introduction
13.3.4 GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.3.5 GW Pharmaceuticals Recent Development
13.4 OPKO Health
13.4.1 OPKO Health Company Details
13.4.2 OPKO Health Business Overview
13.4.3 OPKO Health Dravet Syndrome Treatment Introduction
13.4.4 OPKO Health Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.4.5 OPKO Health Recent Development
13.5 Zogenix
13.5.1 Zogenix Company Details
13.5.2 Zogenix Business Overview
13.5.3 Zogenix Dravet Syndrome Treatment Introduction
13.5.4 Zogenix Revenue in Dravet Syndrome Treatment Business (2015-2020)
13.5.5 Zogenix Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Dravet Syndrome Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Dravet Syndrome Treatment Revenue
Table 3. Ranking of Global Top Dravet Syndrome Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dravet Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of First-generation Drug (FGD)
Table 6. Key Players of Second-generation Drug (SGD)
Table 7. Key Players of Third-generation Drug (TGD)
Table 8. Global Dravet Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Dravet Syndrome Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Dravet Syndrome Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Dravet Syndrome Treatment Market Share by Regions (2015-2020)
Table 12. Global Dravet Syndrome Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Dravet Syndrome Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Dravet Syndrome Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Dravet Syndrome Treatment Players
Table 19. Global Dravet Syndrome Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Dravet Syndrome Treatment Market Share by Players (2015-2020)
Table 21. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Treatment as of 2019)
Table 22. Global Dravet Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Dravet Syndrome Treatment Product Solution and Service
Table 25. Date of Enter into Dravet Syndrome Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Dravet Syndrome Treatment Market Size Share by Type (2015-2020)
Table 29. Global Dravet Syndrome Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Dravet Syndrome Treatment Market Size Share by Application (2015-2020)
Table 31. Global Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Dravet Syndrome Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Dravet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Dravet Syndrome Treatment Market Share (2019-2020)
Table 35. North America Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Dravet Syndrome Treatment Market Share by Type (2015-2020)
Table 37. North America Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Dravet Syndrome Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Dravet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Dravet Syndrome Treatment Market Share (2019-2020)
Table 41. Europe Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Dravet Syndrome Treatment Market Share by Type (2015-2020)
Table 43. Europe Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Dravet Syndrome Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Dravet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Dravet Syndrome Treatment Market Share (2019-2020)
Table 47. China Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Dravet Syndrome Treatment Market Share by Type (2015-2020)
Table 49. China Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Dravet Syndrome Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Dravet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Dravet Syndrome Treatment Market Share (2019-2020)
Table 53. Japan Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Dravet Syndrome Treatment Market Share by Type (2015-2020)
Table 55. Japan Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Dravet Syndrome Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Dravet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Dravet Syndrome Treatment Market Share (2019-2020)
Table 59. Southeast Asia Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Dravet Syndrome Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Dravet Syndrome Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Dravet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Dravet Syndrome Treatment Market Share (2019-2020)
Table 65. India Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Dravet Syndrome Treatment Market Share by Type (2015-2020)
Table 67. India Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Dravet Syndrome Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Dravet Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Dravet Syndrome Treatment Market Share (2019-2020)
Table 71. Central & South America Dravet Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Dravet Syndrome Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Dravet Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Dravet Syndrome Treatment Market Share by Application (2015-2020)
Table 75. Biocodex Company Details
Table 76. Biocodex Business Overview
Table 77. Biocodex Product
Table 78. Biocodex Revenue in Dravet Syndrome Treatment Business (2015-2020) (Million US$)
Table 79. Biocodex Recent Development
Table 80. Epygenix Therapeutics Company Details
Table 81. Epygenix Therapeutics Business Overview
Table 82. Epygenix Therapeutics Product
Table 83. Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2015-2020) (Million US$)
Table 84. Epygenix Therapeutics Recent Development
Table 85. GW Pharmaceuticals Company Details
Table 86. GW Pharmaceuticals Business Overview
Table 87. GW Pharmaceuticals Product
Table 88. GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2015-2020) (Million US$)
Table 89. GW Pharmaceuticals Recent Development
Table 90. OPKO Health Company Details
Table 91. OPKO Health Business Overview
Table 92. OPKO Health Product
Table 93. OPKO Health Revenue in Dravet Syndrome Treatment Business (2015-2020) (Million US$)
Table 94. OPKO Health Recent Development
Table 95. Zogenix Company Details
Table 96. Zogenix Business Overview
Table 97. Zogenix Product
Table 98. Zogenix Revenue in Dravet Syndrome Treatment Business (2015-2020) (Million US$)
Table 99. Zogenix Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dravet Syndrome Treatment Market Share by Type: 2020 VS 2026
Figure 2. First-generation Drug (FGD) Features
Figure 3. Second-generation Drug (SGD) Features
Figure 4. Third-generation Drug (TGD) Features
Figure 5. Global Dravet Syndrome Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. E- Commerce Case Studies
Figure 9. Others Case Studies
Figure 10. Dravet Syndrome Treatment Report Years Considered
Figure 11. Global Dravet Syndrome Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Dravet Syndrome Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Dravet Syndrome Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Dravet Syndrome Treatment Market Share by Players in 2019
Figure 16. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Dravet Syndrome Treatment Revenue in 2019
Figure 18. North America Dravet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Dravet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Dravet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Dravet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Dravet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Dravet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Dravet Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介
  • ドラベ症候群治療薬の世界市場（～2026年）
    Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY11710 2020年11月25日 98Pages
    当調査資料はドラベ症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...
  • クッシング症候群治療の世界市場（～2026年）
    Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11542 2020年11月25日 96Pages
    当調査資料はクッシング症候群治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...
  • バーター症候群治療の世界市場（～2026年）
    Global Bartter Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11022 2020年11月25日 96Pages
    当調査資料はバーター症候群治療のグローバル市場について調査・分析したレポートです。種類別（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素（ACE）阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬...
  • 多嚢胞性卵巣症候群治療の世界市場（～2026年）
    Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04319 2020年11月20日 98Pages
    当調査資料は多嚢胞性卵巣症候群治療のグローバル市場について調査・分析したレポートです。種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤およびSERM、利尿剤）市場規模、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）市場規模、...
  • 慢性疲労症候群治療の世界市場（～2026年）
    Global Chronic Fatigue Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11362 2020年11月25日 99Pages
    当調査資料は慢性疲労症候群治療のグローバル市場について調査・分析したレポートです。種類別（免疫増強剤・抗ウイルス剤、睡眠増強、CNS（中枢神経系）刺激剤）市場規模、用途別（病院、クリニック、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...
  • クッシング症候群・先端巨大症治療の世界市場（～2026年）
    Global Cushing's Syndrome and Acromegaly Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11541 2020年11月25日 92Pages
    当調査資料はクッシング症候群・先端巨大症治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...
  • アスペルガー症候群治療の世界市場（～2026年）
    Global Asperger Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY10910 2020年11月25日 99Pages
    当調査資料はアスペルガー症候群治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法、言語療法、作業療法）市場規模、用途別（病院、クリニック、ドラッグストア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...
  • ウォルフパーキンソンホワイト症候群治療の世界市場（～2026年）
    Global Wolff Parkinson White Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY05113 2020年11月20日 97Pages
    当調査資料はウォルフパーキンソンホワイト症候群治療のグローバル市場について調査・分析したレポートです。種類別（薬物、電気的除細動、手術、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...
  • 腫瘍随伴症候群治療の世界市場（～2026年）
    Global Paraneoplastic Syndrome Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04157 2020年11月20日 98Pages
    当調査資料は腫瘍随伴症候群治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法、理学療法、言語療法、その他）市場規模、用途別（病院、診療所、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...
  • 体位性頻脈症候群（POTS）治療の世界市場（～2026年）
    Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04336 2020年11月20日 99Pages
    当調査資料は体位性頻脈症候群（POTS）治療のグローバル市場について調査・分析したレポートです。種類別（一次フォーム、二次フォーム）市場規模、用途別（病院、診療所、外来外科センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...
  • ドラベ症候群治療薬の世界市場（～2026年）ドラベ症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Dravet Syndrome Thereapeutics Scope and Market Size Dra…
  • 多嚢胞性卵巣症候群治療の世界市場（～2026年）多嚢胞性卵巣症候群治療の世界市場（～2026年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…
  • 化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年）化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…
  • バーター症候群治療の世界市場（～2026年）バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
  • クッシング症候群治療の世界市場（～2026年）クッシング症候群治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…